• SAN FRANCISCO, Dec. 03, 2020 (GLOBE NEWSWIRE) -- HashiCorp®, the leader in multi-cloud infrastructure automation software, today announced it has appointed Kazunari Hanao as its first country manager for Japan. Hanao-san will oversee the company's continued growth in Japan, which will include building out the HashiCorp Japan team, supporting existing and new customers in the region, and continuing to work closely with its distribution partner, Networld, and large system integrator and delivery partners.

  • サンフランシスコ, Dec. 03, 2020 (GLOBE NEWSWIRE) -- マルチクラウドのインフラ自動化ソフトウェアのリーダーであるHashiCorp (HashiCorp® 日本法人:HashiCorp Japan株式会社) は本日、日本のカントリーマネージャーとして花尾 和成 (Kazunari Hanao) が就任したことを発表しました。花尾はHashiCorp Japanのチーム立ち上げや日本における既存顧客や新規顧客のサポート、ディストリビューションパートナー、大手システムインテグレーター、導入パートナーとの緊密な協力関係の継続を含め、同社の日本市場における継続的な成長を指揮して参ります。

  • LONDON, 03 Dec. 2020 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire.

  • SAN DIEGO, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ: PROG) today announced the pricing of its offering of $75.0 million aggregate principal amount of 7.25% convertible senior notes due 2025 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The issuance and sale of the notes are scheduled to settle on December 7, 2020, subject to customary closing conditions. Progenity also granted the initial purchaser of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date notes are first issued, up to an additional $15.0 million principal amount of notes.

  • SAN DIEGO, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Progenity, Inc. (“Progenity”) (NASDAQ: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced the pricing of its previously announced underwritten public offering of 7,645,259 shares of its common stock at a public offering price of $3.27 per share. The gross proceeds of the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Progenity, are expected to be approximately $25.0 million. All of the shares are being offered by Progenity. Progenity has granted the underwriters a 30-day option to purchase up to an additional 1,146,788 shares of common stock at the public offering price, less underwriting discounts and commissions. The offering is expected to close on December 7, 2020, subject to the satisfaction of customary closing conditions. Progenity expects to use the net proceeds from the offering to support its operations, to invest in its molecular testing research and development program, to invest in research and development with respect to its precision medicine platform and for working capital and general corporate purposes.

Corporate Head Office

Construction Today Magazine

Cringleford Business Centre
Intwood Road
Cringleford, Norwich, UK

Click here for a full list of contacts.

North American Office

Construction Today Magazine

Finelight Media
207 E. Ohio Street Suite 351
Chicago, IL 60611

Click here for a full list of contacts.

Back To Top